ALAMEDA, Calif., Dec. 13, 2019 /PRNewswire/ -- Fluxion Biosciences announces the launch of three new targeted NGS liquid biopsy panels: Spotlight Myeloid, Spotlight EGFR, and Spotlight TP53. These new ...
SAN FRANCISCO, Oct. 27, 2016 /PRNewswire/ -- Fluxion Biosciences, Inc. the launch of the Spotlight 59 Oncology Panel. Designed for the detection of mutations from liquid biopsy samples, the Spotlight™ ...
Fluxion Biosciences, a privately held drug discovery tools company, announced today that it has added 4 new senior management positions and expanded sales and technical support globally. The new ...
Fluxion Biosciences Expands IsoFlux Discovery Services Capabilities with Clinical Sample Procurement
Fluxion Biosciences, Inc. announced a new capability to include full-service clinical sample procurement that will expand Fluxion’s IsoFlux Discovery Services offering. Fluxion currently offers a ...
Cellectricon AB and Fluxion Biosciences today announced that they have settled the patent infringement litigation that Cellectricon commenced against Fluxion in 2009. Cellectricon and Fluxion have ...
Built natively on Mantle, Fluxion delivers a modular spot trading infrastructure optimized for capital efficiency, execution quality, and transparency. Rather than serving as a general-purpose DeFi ...
ALAMEDA, Calif., Dec. 13, 2019 /PRNewswire/ -- Fluxion Biosciences announces the launch of three new targeted NGS liquid biopsy panels: Spotlight Myeloid, Spotlight EGFR, and Spotlight TP53. These new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results